Tumor Microenvironment
A section of Cancers (ISSN 2072-6694).
Section Information
The MDPI journal Cancers has recently defined the scope and have introduced a Tumor Microenvironment Section. The TME section aims to publish high-quality research on the molecular and cellular components of cancer microenvironment, with a particular focus on basic, translational and clinical research that has significant implications for the diagnosis, prevention and treatment of human malignancies. The subject area include, but not limited to, the mechanisms playing essential role in tumor cell plasticity under the influence of unique microenvironment, molecular and cellular markers for diagnosis, prognosis, drug targets in malignant cells and its microenvironment, and the role of microbiome in influencing the etiology and characteristics of cancer cell. The section also encourages communication of scientific advancement in complementary and alternative medicines influencing tumor microenvironment.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Understanding Hodgkin’s Lymphoma: The Role of Tumour Cells and Immune Microenvironment (Deadline: 29 November 2024)
- Apoptosis in Cancer 2.0 (Deadline: 30 November 2024)
- Role of Autophagy in Cancer Stem Cells and the Tumor Microenvironment: New Frontiers in Cancer Drug Discovery (Deadline: 30 November 2024)
- Microenvironment and Metastasis in Breast and Gynecological Tumors (Deadline: 30 November 2024)
- Cytokines in Cancer Immunotherapy (2nd Edition) (Deadline: 30 November 2024)
- Heat Shock Proteins in Cancers (Deadline: 15 December 2024)
- Circulating Tumor Cells: Origin, Fate, and Roles in Immune Evasion and Metastasis (Deadline: 15 December 2024)
- Emerging Therapeutic Approaches for Gastrointestinal Malignancies and the Tumour Microenvironment (Deadline: 15 December 2024)
- Tumor-Initiating Cells in Breast Cancer: From Bench to Bedside (Deadline: 15 December 2024)
- Autophagy–EMT Interrelations: At the Core of Tumor Transformation (Deadline: 20 December 2024)
- The Role of Genes in Prostate Cancer (Deadline: 25 December 2024)
- Tumor Immune Microenvironment in Gastric Cancers (Deadline: 25 December 2024)
- Integrins and Tumor Microenvironment, New Perspectives in Targeted Treatments (Deadline: 31 December 2024)
- Cancer Cell Communications, Metastasis and Survival in Host Microenvironment (Deadline: 31 December 2024)
- State-of-the-Art Treatment on Chemotherapy and Immunotherapy for Urological Cancer (Deadline: 31 December 2024)
- Circulating Tumor Cells (CTCs): Current and Emerging Utility in Cancer (Deadline: 31 December 2024)
- Trop-2 and Its Overexpression in Cancers: Signaling Pathways, Function, Clinical/Therapeutic Implications (Deadline: 31 December 2024)
- G Protein-Coupled Receptors in Cancer Progression (Deadline: 31 December 2024)
- Oral Cancer and the Microbiome (Deadline: 31 December 2024)
- Advances in Chronic Lymphocytic Leukaemia (CLL) Research (Deadline: 31 December 2024)
- Radiation Exposure, Inflammation and Cancers (Deadline: 10 January 2025)
- Treatment of Peripheral T-cell Lymphomas (Deadline: 15 January 2025)
- Emerging Role of Exosomes in Comorbidity-Associated Cancer Progression (Deadline: 15 January 2025)
- Proteomic and Genomic Profiling of Pancreatic Cancer (Deadline: 31 January 2025)
- Non-Coding RNAs in the Tumor Microenvironment (Deadline: 1 February 2025)
- State-of-the-Art Strategies for Non-Coding RNA Function Detection and Regulation in Cancer (Deadline: 10 February 2025)
- Inhibitors in Chronic Myeloid Leukemia (Deadline: 20 February 2025)
- Metabolic Adaptations in Cancer (Deadline: 25 February 2025)
- Ovarian Cancer Stem Cells and Tumor Microenvironment (Deadline: 28 February 2025)
- The Extracellular Matrix in Cancer Ecosystems: Functional Contributions and Targeting Opportunities (Deadline: 28 February 2025)
- Advances in Acidosis within the Tumor Microenvironment (Deadline: 28 February 2025)
- Heme Metabolism in Oncogenesis and Tumor Microenvironment: Mechanisms and Emerging Therapeutic Strategies (Deadline: 1 March 2025)
- The Role of Regucalcin in Cancer (Deadline: 1 March 2025)
- Targeting TGF-β as a Marker and Pharmacological Target against Cancer (Deadline: 15 March 2025)
- Tumor Microenvironment of Breast Cancer (Deadline: 15 March 2025)
- The New Challenge of Curing AML: Analysis of Mechanisms of Resistance of Target Drugs and Future Perspectives (Deadline: 20 March 2025)
- Targeting the Sphingolipid Metabolic Pathway: Promotion from Benchwarmer to the Starting Lineup—a Themed Issue in Memory of Drs. Lina Obeid and Mark Kester (Deadline: 25 March 2025)
- Advanced Glycation End-Products and Its Receptors in Cancer Progression (Deadline: 31 March 2025)
- Lymph Node Involvement in Cervical Cancer: From Single Isolated Tumor Cell to Macrometastasis (Deadline: 31 March 2025)
- Neurofibromatosis Type 1 (NF1) Related Tumors (Deadline: 31 March 2025)
- Extracellular Vesicles (EVs) in Cancer Diagnostics and Therapy (Deadline: 31 March 2025)
- Insights into Cancer Stem Cells (Deadline: 31 March 2025)
- The Role of Tumor Microenvironment in Solid Tumors: Development of Cancer Research (Deadline: 31 March 2025)
- Genome Instability and Human Cancer (Deadline: 15 April 2025)
- The Tumor Microenvironment and Its Role in Tumor Growth and Angiogenesis (Deadline: 15 April 2025)
- Role of Cytokines in Cancer (Deadline: 30 April 2025)
- Role of Extracellular Vesicles in Cancer Progression (Deadline: 30 April 2025)
- Targeting the Tumor Microenvironment (Volume II) (Deadline: 30 April 2025)
- The Tumor Microenvironment: Interplay Between Immune Cells (Deadline: 30 April 2025)
- Signaling Pathways of Breast Cancer (Deadline: 30 May 2025)
- Effects of Radiotherapy on the Tumor Microenvironment (Deadline: 30 May 2025)
- Human Microbiome, Diet and Cancerogenesis (Deadline: 31 May 2025)
- Oncogenic Driver Mutations and Signaling Pathways in Tumorigenesis and Therapy in Lung Cancer (Deadline: 31 May 2025)
- Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk (Deadline: 1 June 2025)
- The Warburg Effect in Cancers (Deadline: 30 June 2025)
- Epigenetic Regulation in Hematologic Malignancies (Deadline: 30 June 2025)
- Advances in Bacteria and Cancer (Deadline: 15 July 2025)
- Relationship between Protein and Metabolite in Cancers (Deadline: 20 July 2025)
- EVs and EPS in Cancer: Cell-to-Cell Communication, Diagnosis, and Evaluation of Cancer Therapy Response (Deadline: 20 July 2025)
- Extracellular Matrix Proteins in Cancer (Deadline: 31 July 2025)
- Targeted Therapies for Cancer Metastasis (Deadline: 31 July 2025)
- Epigenetic Regulation in Cancers (Deadline: 10 August 2025)
- Novel Insights into Microenvironment of Leukemia (Deadline: 20 August 2025)
- Signaling Networks Controlling Ovarian Cancer Progression and Response to Therapy (Deadline: 31 August 2025)
- The Role of Autophagy in Brain Tumors (Volume II) (Deadline: 31 August 2025)
- MicroRNA and Cancer Immunology (Deadline: 15 September 2025)
- Endothelial Cells in Inflammation, Tissue Repair, Ageing and Cancer: 2nd Edition (Deadline: 15 September 2025)
- Advances in Chronic Lymphocytic Leukemia Microenvironment: The Disruption of the Supportive Leukemic/Accessory Cells Interactions to Improve Therapy Response, 2nd Edition (Deadline: 30 September 2025)
- The Influence of Epigenetic Regulation on the Tumor Microenvironment: Mechanisms and Therapeutic Implications (Deadline: 30 September 2025)
- Tumor Microenvironment Dynamics in Hepatocellular Carcinoma (Deadline: 30 September 2025)
- Aberrant Cytokine Receptor Signaling in Hematological Cancers and Proliferative Disorders (Deadline: 20 November 2025)
- Epigenetic and Metabolic Alterations in the Tumor Microenvironment: 2nd Edition (Deadline: 21 November 2025)
- Post-transcriptional Regulation of Cancer-Related Processes (Deadline: 1 December 2025)
- Latest Breakthroughs in Tumor Immune Microenvironment: From Cellular Discovery to Cutting-Edge Technology (Deadline: 5 December 2025)
- New Molecular Targets and Emerging Approaches to Target Cancer Stem Cells (Deadline: 15 December 2025)
- Feature Papers in Section "Tumor Microenvironment" (Deadline: 31 December 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications
- Kinases and Cancer (Closed)
- Matrix Effectors and Cancer (Closed)
- Molecular Signaling Pathways and Networks in Cancer
- New Discoveries and Future Trend for Prostate Cancer Research and Treatment
- Targeting Solid Tumors
